ID

28998

Description

A phase IV, open, multicentre study to assess the immunogenicity and reactogenicity of GlaxoSmithKline Biologicals’ DTPa-HBV-IPV/Hib vaccine (Infanrix hexa) given as a booster at 18-24 months of age to pre-term children who have received a three-dose primary immunization course with the same vaccine in study 217744/090.

Mots-clés

Versions (1)
  1. 20/02/2018 20/02/2018 -
Détendeur de droits

GlaxoSmithKline (GSK)

Téléchargé le

20 février 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Biologicals’ DTPa-HBV-IPV/Hib vaccine (Infanrix-hexa) Study ID: 101518

Anglais

Swelling assessment No.2

2 Formulaires  
Report of physical examination and case clinical description
Description

Report of physical examination and case clinical description

Alias
UMLS CUI-1
C0031809
Date of physical examination
Description

Date

Type de données

date

Alias
UMLS CUI [1]
C0011008
Was the examination performed by a member of study personnel during the extensive swelling period :
Description

Examiner

Type de données

boolean

Alias
UMLS CUI [1]
C0025082
Date when the swelling was first considered to be extensive:
Description

Date of first extensive swelling

Type de données

date

Alias
UMLS CUI [1,1]
C0038999
UMLS CUI [1,2]
C2700396
UMLS CUI [1,3]
C0205231
UMLS CUI [1,4]
C0011008
If occurring within 24 hours after vaccination, please specify how long after vaccination:
Description

Date of fist extensive swelling

Type de données

integer

Unités de mesure
  • hours
Alias
UMLS CUI [1,1]
C0038999
UMLS CUI [1,2]
C2700396
UMLS CUI [1,3]
C0205231
UMLS CUI [1,4]
C0011008
hours
Please give a clinical description of the observed extensive swelling, including a description of the joint involved and specific associated symptoms. Please mention also eventual diagnostic(s)
Description

Swelling case description

Type de données

text

Alias
UMLS CUI [1,1]
C0449437
UMLS CUI [1,2]
C0678257
UMLS CUI [1,3]
C0038999
Retour au début de la page

Similar models

Swelling assessment No.2

2 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Date
Item
Date of physical examination
date
C0011008 (UMLS CUI [1])
Examiner
Item
Was the examination performed by a member of study personnel during the extensive swelling period :
boolean
C0025082 (UMLS CUI [1])
Date of first extensive swelling
Item
Date when the swelling was first considered to be extensive:
date
C0038999 (UMLS CUI [1,1])
C2700396 (UMLS CUI [1,2])
C0205231 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
Date of fist extensive swelling
Item
If occurring within 24 hours after vaccination, please specify how long after vaccination:
integer
C0038999 (UMLS CUI [1,1])
C2700396 (UMLS CUI [1,2])
C0205231 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
Swelling case description
Item
Please give a clinical description of the observed extensive swelling, including a description of the joint involved and specific associated symptoms. Please mention also eventual diagnostic(s)
text
C0449437 (UMLS CUI [1,1])
C0678257 (UMLS CUI [1,2])
C0038999 (UMLS CUI [1,3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial